Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China

This study has been completed.
Sponsor:
Information provided by:
The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
NCT00951262
First received: August 3, 2009
Last updated: February 10, 2014
Last verified: August 2009
  Purpose

This study aims to develop a life review program and test its effectiveness on a sample of patients with advanced cancer patients receiving palliative care at home in Fuzhou.


Condition Intervention Phase
Advanced Cancer
Behavioral: a life review program
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Development and Evaluation of a Life Review Program for Advanced Cancer Patients in Fuzhou, China

Resource links provided by NLM:


Further study details as provided by The Hong Kong Polytechnic University:

Primary Outcome Measures:
  • quality of life [ Time Frame: three weeks and six weeks ] [ Designated as safety issue: No ]

Enrollment: 80
Study Start Date: February 2009
Study Completion Date: June 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: life review
a life review program includes 3-session life review and formulation of a life review book as a gift for advanced cancer patients.
Behavioral: a life review program
The life review program includes reviewing a life and formalating a life booklet. Reviewing a life consists of three weekly sessions separately addressing illness experience, adulthood life and childhood and adolescence life. Each session lasts about 30 to 60mintues.A booklet with photos documented significant life events will be produced as a gift for the subjects. The edition, photos and contents fo the booklet are determined by the subjects.
Other Name: evaluative reminence
No Intervention: controlled group
the subjects in the controlled group do not receive the life review program

Detailed Description:

A life review program is mainly developed based on Erickson's theory, Confucius's teaching on human development, and the empirical findings of the researcher's preliminary study and pre-pilot study. The program covers reviewing a life for advanced cancer patients and formulating a booklet for them. A randomized controlled trial will be adopted for evaluation of this program. Eligible patients will be randomly assigned to the experimental group and the control group. The subjects in the experimental group will receive a life review program for three weeks. The outcome measure is quality of life (QOL), including domains of physical discomfort, food-related concerns, health care concerns, support, negative emotions, sense of alienation, existential distress and value of life. Subjects' QOL will be assessed before commencement of the program (T0) and one day (T1) and three weeks (T2) after the completion of the program for all subjects in two groups. Perceptions of the program will be elicited within three days after the program for subjects in the experimental group.Descriptive statistics will be used to analyze patients' personal information, disease related information, functional performance and QOL of advanced cancer patients. Repeated measures ANOVA will be used to measure QOL differences in between-group, within-group and interaction effects. Content analysis will be used to analyze the qualitative data collected.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients who are newly admitted to the study hospice
  2. Patients who are suffering from cancer with metastasis made by a physician
  3. Patients who know their diagnosis, prognosis and therapy
  4. Patients' functional performance (the score of KPS) at or more than 50%
  5. Patients who are adults (≥18 years old)
  6. Patients who have no cognitive and verbal communication impairments

Exclusion Criteria:

  1. Patients with planned treatments, such as chemotherapy, radiotherapy or surgery
  2. Patients with psychiatric disorders
  3. Patients who live outside Fuzhou since the following-up home visit services are not extended to those areas
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00951262

Locations
China, Fujian
The Fujian Hospice
Fuzhou, Fujian, China, 350001
Sponsors and Collaborators
The Hong Kong Polytechnic University
Investigators
Principal Investigator: Enid Kwong, PhD School of Nursing, The Hong Kong Polytechnic University
  More Information

No publications provided

Responsible Party: Enid Kwong, School of Nursing, The Hong Kong Polytechinich University
ClinicalTrials.gov Identifier: NCT00951262     History of Changes
Other Study ID Numbers: HSEARS20090205002
Study First Received: August 3, 2009
Last Updated: February 10, 2014
Health Authority: China: Ethics Committee

Keywords provided by The Hong Kong Polytechnic University:
life review
quality of life
advanced cancer patients

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on September 30, 2014